Jiawen Dai
机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital
发表论文 3 篇 · 总被引 13 次 · h-index 2
代表论文
- Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
- The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis (2024 · Human Vaccines & Immunotherapeutics · 被引 6)
- Long-term efficacy and safety of low-dose rituximab in immune thrombocytopenia: a multicentre, prospective, open-label, randomised controlled trial (2026 · Annals of Hematology · 被引 1)